arrow
M

Michele Dal Bo

centro di riferimento oncologico irccs
H指数:37
被引数:4,380

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The anti-GPC1 antibody AT101 as effective targeting agent for chemotherapeutic-loaded chitosan nanobubbles in the treatment of pancreatic adenocarcinoma

抗-GPC1抗体AT101作为化疗药物负载壳聚糖纳米气泡在胰腺腺癌治疗中的有效靶向剂

2026-09-260
OA
Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma

更正:Spry1的抑制降低了BRAF突变型皮肤黑色素瘤中HIF1α依赖的糖酵解并损害了血管生成

2026-08-210
OAAI
Molecular Characterization of Adult-Type Lower-Grade Glioma (WHO Grade 1–3) with Targeted Next-Generation Sequencing: A Retrospective, Single-Institution Experience

成人型低级别胶质瘤(WHO 1–3级)的分子特征分析:靶向二代测序研究——一项回顾性单中心研究

2025-12-210
OAAI
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab
2023-06-211
OAAI